31 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25549897	36	Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as selective agonists of human formyl-peptide receptor 2.	Universit£
25587631	5	Pachymodulin, a new functional formyl peptide receptor 2 peptidic ligand isolated from frog skin has Janus-like immunomodulatory capacities.	Sorbonne University
25035262	41	Development of potent antagonists for formyl peptide receptor 1 based on Boc-Phe-D-Leu-Phe-D-Leu-Phe-OH.	Saga University
25254640	64	Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2.	Syntrix Biosystems
22094028	31	Lead optimisation of pyrazoles as novel FPR1 antagonists.	Astrazeneca
21955939	49	Discovery of pyrazoles as novel FPR1 antagonists.	Astrazeneca
21486695	11	Discovery of small molecule human FPR1 receptor antagonists.	Astrazeneca
17475488	13	2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis.	Universit£
12361388	47	Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.	Strasbourg 1 University
19639995	81	6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.	Universita Degli Studi Di Firenze
31038950	104	Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.	Monash University
31913038	13	Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity.	University of Florida
8676333	46	N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.	Johnson Matthey Biomedical Research
23276447	7	A formyl peptide substituted with a conformationally constrained phenylalanine residue evokes a selective immune response in human neutrophils.	Saga University
29102463	43	Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation.	Universit£
	6	NAD+-dependent DNA ligase (Rv3014c) from M. tuberculosis: Strategies for inhibitor design	Central Drug Research Institute
	10	Design and synthesis of new 2-aryl, 3-benzyl- (1,3-oxazolidine or 1,3-thiazolidine)-4-ones as selective cyclooxygenase (COX-2) inhibitor	Shahid Beheshti University